Most people in legal marketing have a clean lane. They either run motor-vehicle accident campaigns, or they run mass tort intake. The two markets share a vocabulary but operate on completely different unit economics — and the funnels you build for one bleed into the other in ways you don't appreciate until you've run both.
Between 2021 and 2025 we ran active campaigns across five major mass-tort dockets — Camp Lejeune, talcum / Johnson & Johnson, AFFF firefighting foam (PFAS), Roundup, and the early ozempic / Mounjaro injury inventory. Average per-claimant fee in those torts ran between $25,000 and $110,000. Average MVA case fee — depending on state and severity — runs $8,000 to $35,000. The operational consequences of that 5–10× spread on how you build a funnel are non-obvious.
Here are the five lessons that transferred straight into MVA Leads, and the one that didn't.
§ I · Lesson 1Bid on the signed claimant, not the lead.
Camp Lejeune in particular taught us this — fast. A Camp Lejeune lead at $40 looked great until you realized the qualification requirements (proof of stationed service between 1953 and 1987, documented diagnosis, no prior counsel) meant 90% of leads washed out. The viable acquisition target was always the signed claimant, and we restructured every platform's bid objective to look at that event.
When we started MVA Leads, signed-case CPA bidding wasn't an aspiration — it was the assumption. The underlying mechanic is the same: feed the platform the signal that actually matters to the firm, not the noisy upstream proxy. On MVA the math is gentler (you're not screening for 70-year-old service history) but the principle is identical. We covered the mechanics in Field Note No. 02.
§ II · Lesson 2Bilingual intake is the difference between mediocre and excellent.
AFFF inventory in 2024 was concentrated in military-adjacent population centers, which in places like San Antonio, Jacksonville, and Norfolk includes very meaningful Spanish-speaking populations. Talc inventory tilted the same way through Florida, California, and Texas. The firms we ran with bilingual intake from day one consistently signed 18–30% more claimants per qualified lead than firms with English-only intake.
That number ports almost directly to MVA. Los Angeles, Houston, Miami, the Rio Grande Valley — the demand profile is identical. The reason we set up Spanish MVA lead supply on day one of MVA Leads is that we'd watched bilingual intake be the single biggest sign-rate lever in mass tort four years running.
§ III · Lesson 3Settlement runways compress fast. Build for it.
Camp Lejeune is the canonical example. The Justice for Camp Lejeune Act passed in August 2022. By Q2 2024, the Department of the Navy had received over 200,000 claims. The early-tier settlement framework arrived in fall 2024. From "you can file" to "settlements actively paying" was roughly 26 months — fast for a federal claims program, brutal for a media-buying agency that needed to flex spend across 30-day arcs.
What we learned: when a tort's settlement signals shift, your bidding shifts inside 72 hours, not 6 weeks. You watch the MDL docket like a stock ticker. The pre-trial settlement framework changes — boom, ad spend up 40% the same week, because every firm in the space is going to compete for the same inventory.
MVA doesn't have settlement-window drama at the docket level, but it has the same effect at the seasonal level. Q1 is the fluffiest market every year (people are sober, not driving). July 4th week is the highest. Friday afternoon of every NFL weekend in the South is its own micro-spike. We adjusted MVA Leads' state-level seat counts to flex against those windows because the mass-tort experience made it second nature.
§ IV · Lesson 4Intake is relational, not transactional.
You can not run a successful Camp Lejeune intake call as a screener. The prospects are veterans or their surviving family members. Half of them are calling because they finally heard the news on local TV; the other half are dealing with a terminal diagnosis and have a 72-year-old mother who lived on base in 1965. The "qualify them in 60 seconds" intake script that works for a fender-bender breaks the moment that prospect picks up the phone.
What we wrote in mass tort: the first 8 seconds are about the human, the next 30 seconds are about acknowledgment, the qualification questions come second-half. When the same pattern ran for a four-attorney PI firm in Tampa, signed-case rate doubled inside 11 weeks. That was the bones of Field Note No. 03.
§ V · Lesson 5Server-side conversion tracking matures faster on bigger CPAs.
At a $40 CPL with a $25K per-claimant fee, a 10-point match- quality gap on your Meta Lead event is real money. We had Meta CAPI running on every mass-tort campaign by mid-2023 because the cost of not having it was visible in the next week's report. Same with Google's Enhanced Conversions — deployed first across mass tort, then ported to MVA.
The general rule: the bigger your CPA, the earlier you'll tolerate the implementation pain of server-side tracking. By the time we started MVA Leads, that infrastructure was a checklist, not a project. Every form submission on this site now fires server-side to Meta, Google, and TikTok with hashed PII, fbp/fbc, IP, user-agent, and a deterministic event ID for browser dedup.
§ VI · The lesson that didn't transferInventory scarcity behaves opposite in MVA.
In mass tort, inventory shrinks as a tort matures. Eligible claimants exist in a finite pool. As that pool gets worked over by intake operators, CPL inflates and qualification rates fall. By the late stages of a tort (Roundup in 2024 is the textbook case), CPL has tripled vs the early days and the marginal lead is a long-time researcher who's already talked to three firms.
MVA doesn't work like that. Accident inventory regenerates every single day. The total addressable claimant pool isn't finite — it's a function of traffic, weather, distracted driving, and the size of the state. A market doesn't get "worked through." It refreshes.
The mistake we almost made onboarding the first cohort of MVA Leads buyers was treating supply like mass tort: assume CPL will inflate over time, price defensively. Wrong instinct. Exclusive MVA CPL stays stable for years if the underlying campaigns are managed properly. We re-priced our standard tier accordingly — flat CPL, month-to-month, scale up freely. The mass-tort scarcity reflex would have made our model uncompetitive.
§ VII · Why this matters for youThe strategic takeaway.
If you're a PI firm thinking about buying MVA leads from a vendor whose only experience is MVA, ask them how they bid. If the answer is "we optimize for cost-per-lead," they have not yet absorbed the lesson that mass-tort operators learned on someone else's $90K fees. The platforms reward whatever signal you feed them. Most vendors are feeding them the wrong signal. We learned that one the expensive way.
Mass-tort campaign experience reflects active work via MassTortAgency.net across Camp Lejeune, talcum/J&J, AFFF, Roundup, and ozempic dockets between 2021 and 2025. Per-tort and per-firm campaign detail redacted under client confidentiality. Read the 2024 annual postmortem for the full year of context, or see how exclusive MVA supply works on our side.
